Aveanna Healthcare Stock 23% Jump: Why a Fund Sold $16M
Aveanna Healthcare stock jumped 23%, but a major fund still sold $16 million of AVAH shares. This article breaks down...
Compare long-run outcomes for index versus active strategies, emphasizing time horizons, persistence of outperformance, and practical takeaways.
27,723 articlesAveanna Healthcare stock jumped 23%, but a major fund still sold $16 million of AVAH shares. This article breaks down...
As earnings season rolls in, KTCC’s tronic 2026 earnings story becomes a focal point for value seekers. This guide br...
XLY relies heavily on two megacaps, exposing the fund to outsized moves from Amazon and Tesla and prompting renewed q...
ARTY posted a 12-month gain of 28.3%, topping QQQ's 14.3% and SPY's 13.7%, as AI infrastructure exposure draws buyers...
ExxonMobil hovers around $150 as traders weigh mixed earnings against a long dividend-growth streak. The stock has ju...
Markets push higher on resilient earnings and a sturdy job market, with recession risk receding for 2026. Yet traders...
A draft tax package for digital assets circulates ahead of a House Ways and Means hearing next week. It would require...
A looming 2027 COLA could lift benefits by billions, but inflation momentum and policy hurdles threaten social securi...
Elon Musk’s wealth narrowed dramatically after SpaceX’s IPO, underscoring how quickly fortunes hinge on a single comp...
A top Moody’s economist argues AI-related costs are propping up inflation, not damping it. He warns relief won’t arri...
Ed Yardeni maintains that AI-driven earnings momentum drives the market, predicting the S&P 500 will reach 8,250 by y...
The U.S. intensified strikes on Iran for a ninth night as Tehran attacked Gulf allies, pushing oil prices higher and ...